SARS-CoV-2 articles within Scientific Reports

Featured

• Article
  29 May 2024 | Open Access

  Kinetics of SARS-CoV-2 infection biomarkers in a household transmission study

  • Ana M. Groh
  • , Maria J. G. T. Vehreschild
  •  & Annemarie Berger

• Article
  28 May 2024 | Open Access

  PMMA dialyzers modulate both humoral and cell-mediate immune response to anti-COVID-19 vaccine (BNT162b2) in a cohort of chronic hemodialyzed patients

  • Giuseppe Castellano
  • , Giuseppe Stefano Netti
  •  & Giovanni Stallone

• Article
  16 May 2024 | Open Access

  Assessment of smell disturbances 6 months after COVID-19 in Polish population

  • Jakub Okrzeja
  • , Sebastian Sołomacha
  •  & Anna Moniuszko-Malinowska

• Article
  09 May 2024 | Open Access

  Genomic characterization of Influenza A (H1N1)pdm09 and SARS-CoV-2 from Influenza Like Illness (ILI) and Severe Acute Respiratory Illness (SARI) cases reported between July–December, 2022

  • Pushpendra Singh
  • , Kuldeep Sharma
  •  & Sanjay Singh Negi

• Article
  16 April 2024 | Open Access

  SARS-CoV-2 infection activates inflammatory macrophages in vascular immune organoids

  • Chiu Wang Chau
  • , Alex To
  •  & Ryohichi Sugimura

• Article
  02 April 2024 | Open Access

  Detection of SARS-COV-2 variants and their proportions in wastewater samples using next-generation sequencing in Finland

  • Anssi Lipponen
  • , Aleksi Kolehmainen
  •  & Carita Savolainen-Kopra

• Article
  02 April 2024 | Open Access

  SARS-CoV-2 variant with the spike protein mutation F306L in the southern border provinces of Thailand

  • Thanit Sila
  • , Smonrapat Surasombatpattana
  •  & Pakorn Aiewsakun

• Article
  29 March 2024 | Open Access

  Faster detection of asymptomatic COVID-19 cases among care home staff in England through the combination of SARS-CoV-2 testing technologies

  • Finola Ryan
  • , Joanna Cole-Hamilton
  •  & Tom Fowler

• Article
  27 March 2024 | Open Access

  Stability, homogeneity and measurement uncertainty estimation of PVP-I solutions for the application on oro and nasopharynx against SARS-CoV-2

  • Md. Moniruzzaman
  • , Mamudul Hasan Razu
  •  & Mala Khan

• Article
  17 March 2024 | Open Access

  Aesculus hippocastanum extract and the main bioactive constituent β-escin as antivirals agents against coronaviruses, including SARS-CoV-2

  • Freddy Armando Peñaranda Figueredo
  • , Josefina Vicente
  •  & Carlos Alberto Bueno

• Article
  13 March 2024 | Open Access

  Exploring cell-free assays for COVID-19 serosurvey

  • Lucia Inchauste
  • , Elif Nurtop
  •  & Stéphane Priet

• Article
  11 March 2024 | Open Access

  Point-of-care lung ultrasound predicts hyperferritinemia and hospitalization, but not elevated troponin in SARS-CoV-2 viral pneumonitis in children

  • Paul Walsh
  • , Andrea Hankins
  •  & Heejung Bang

• Article
  04 March 2024 | Open Access

  Molecular characterization of SARS-CoV-2 Omicron clade and clinical presentation in children

  • Rossana Scutari
  • , Valeria Fox
  •  & Claudia Alteri

• Article
  03 March 2024 | Open Access

  The clinical features, treatment and prognosis of neutropenic fever and Coronavirus disease 2019 results of the multicentre teos study

  • Dilşah Başkol Elik
  • , Şafak Kaya
  •  & Oguz Resat Sipahi

• Article
  14 February 2024 | Open Access

  Immunological mechanisms of the nucleocapsid protein in COVID-19

  • Fahime Edalat
  • , Niloofar Khakpour
  •  & Afagh Moattari

• Article
  06 February 2024 | Open Access

  A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death

  • Francesca Minnai
  • , Filippo Biscarini
  •  & Francesca Colombo

• Article
  02 February 2024 | Open Access

  Binding behavior of receptor binding domain of the SARS-CoV-2 virus and ivermectin

  • Kasidy R. Gossen
  • , Meiyi Zhang
  •  & Maria D. King

• Article
  29 January 2024 | Open Access

  Cycle threshold of SARS-CoV-2 RT-PCR as a driver of retesting

  • Robert Markewitz
  • , Justina Dargvainiene
  •  & Klaus-Peter Wandinger

• Article
  25 January 2024 | Open Access

  Development of a pseudo-typed virus particle based method to determine the efficacy of virucidal agents

  • Jordan Thomas
  • , Farah Mughal
  •  & Michael Hoptroff

• Article
  19 January 2024 | Open Access

  Microstructural brain abnormalities, fatigue, and cognitive dysfunction after mild COVID-19

  • Lucas Scardua-Silva
  • , Beatriz Amorim da Costa
  •  & Clarissa Lin Yasuda

• Article
  16 January 2024 | Open Access

  Multicentric evaluation of sensitivity of eight commercial anti-SARS-CoV-2 antibody assays and their correlation to virus neutralization titers in seropositive subjects

  • Miroslav Fajfr
  • , Petr Pajer
  •  & Pavel Bostik

• Article
  06 January 2024 | Open Access

  The death rate of COVID-19 infection in different SARS-CoV-2 variants was related to C-reactive protein gene polymorphisms

  • Sahar Sadeghi Mofrad
  • , Shayan Boozarjomehri Amnieh
  •  & Abolfazl Fateh

• Article
  05 January 2024 | Open Access

  Genomic epidemiology and evolutionary analysis during XBB.1.16-predominant periods of SARS-CoV-2 omicron variant in Bangkok, Thailand: December 2022–August 2023

  • Jiratchaya Puenpa
  • , Jira Chansaenroj
  •  & Yong Poovorawan

• Article
  04 January 2024 | Open Access

  Recombination-aware phylogenetic analysis sheds light on the evolutionary origin of SARS-CoV-2

  • Luis Roger Esquivel Gomez
  • , Ariane Weber
  •  & Denise Kühnert

• Article
  18 December 2023 | Open Access

  Demographics, clinical characteristics, and outcomes in hospitalized patients during six waves of COVID‑19 in Northern Iran: a large cohort study

  • Hoda Shirafkan
  • , Farzin Sadeghi
  •  & Yousef Yahyapour

• Article
  14 December 2023 | Open Access

  Development of a quantum dot-based lateral flow immunoassay strip for rapid and sensitive detection of SARS-CoV-2 neutralizing antibodies

  • Xirong Wang
  • , Shulin Shao
  •  & Bo Tang

• Article
  14 December 2023 | Open Access

  Unravelling the effect of New Year’s Eve celebrations on SARS-CoV-2 transmission

  • Caspar Geenen
  • , Jonathan Thibaut
  •  & Emmanuel André

• Article
  12 December 2023 | Open Access

  Stability of Feline Coronavirus in aerosols and dried in organic matrices on surfaces at various environmental conditions

  • Janina Reissner
  • , Paul Siller
  •  & Anika Friese

• Article
  09 December 2023 | Open Access

  A bead-based multiplex assay covering all coronaviruses pathogenic for humans for sensitive and specific surveillance of SARS-CoV-2 humoral immunity

  • Daniel Stern
  • , Tanja C. Meyer
  •  & Brigitte G. Dorner

• Article
  06 December 2023 | Open Access

  Variation in presepsin and thrombomodulin levels for predicting COVID-19 mortality

  • Azusa Yamazaki
  • , Yoko Nukui
  •  & Ryunosuke Ohkawa

• Article
  04 December 2023 | Open Access

  Effectiveness of VSV vectored SARS-CoV-2 spike when administered through intranasal, intramuscular or a combination of both

  • Saina Beitari
  • , Gerard Agbayani
  •  & Anh Tran

• Article
  04 December 2023 | Open Access

  In silico drug repurposing carvedilol and its metabolites against SARS-CoV-2 infection using molecular docking and molecular dynamic simulation approaches

  • Chunye Zhang
  • , Jiazheng Liu
  •  & Ming Yang

• Article
  01 December 2023 | Open Access

  Infectivity of exhaled SARS-CoV-2 aerosols is sufficient to transmit covid-19 within minutes

  • Malin Alsved
  • , Kristina Nyström
  •  & Jakob Löndahl

• Article
  22 November 2023 | Open Access

  Genomic characterization of SARS-CoV-2 from Uganda using MinION nanopore sequencing

  • Praiscillia Kia
  • , Eric Katagirya
  •  & David Patrick Kateete

• Article
  20 November 2023 | Open Access

  Use of a point-of-care test to rapidly assess levels of SARS-CoV-2 nasal neutralising antibodies in vaccinees and breakthrough infected individuals

  • Chee Wah Tan
  • , Chuan Kok Lim
  •  & Danielle E. Anderson

• Article
  18 November 2023 | Open Access

  Humoral immunogenicity assessment after receiving three types of SARS-CoV-2 vaccine

  • Niloofar Najafi
  • , Hoorieh Soleimanjahi
  •  & Zeynab Nasiri

• Article
  16 November 2023 | Open Access

  Inactivation of human coronaviruses using an automated room disinfection device

  • Nicholas A. Lundquist
  • , Legesse G. Kifelew
  •  & Justin M. Chalker

• Article
  26 October 2023 | Open Access

  Assessment of hybrid population immunity to SARS-CoV-2 following breakthrough infections of distinct SARS-CoV-2 variants by the detection of antibodies to nucleoprotein

  • Gerco den Hartog
  • , Stijn P. Andeweg
  •  & Robert S. van Binnendijk

• Article
  19 October 2023 | Open Access

  Utility of nasal swabs for assessing mucosal immune responses towards SARS-CoV-2

  • Ericka Kirkpatrick Roubidoux
  • , Pamela H. Brigleb
  •  & Stacey Schultz-Cherry

• Article
  14 October 2023 | Open Access

  Tracking SARS-CoV-2 Omicron lineages using real-time reverse transcriptase PCR assays and prospective comparison with genome sequencing

  • Nathan Zelyas
  • , Kanti Pabbaraju
  •  & Graham Tipples

• Article
  20 September 2023 | Open Access

  Seroprevalence of SARS-CoV-2 anti-nucleocapsid total Ig, anti-RBD IgG antibodies, and infection in Thailand: a cross-sectional survey from October 2022 to January 2023

  • Jira Chansaenroj
  • , Nungruthai Suntronwong
  •  & Yong Poovorawan

• Article
  13 September 2023 | Open Access

  Differential abundance of lipids and metabolites related to SARS-CoV-2 infection and susceptibility

  • Oihane E. Albóniga
  • , Elena Moreno
  •  & Sergio Serrano-Villar

• Article
  06 September 2023 | Open Access

  Surveillance of Vermont wildlife in 2021–2022 reveals no detected SARS-CoV-2 viral RNA

  • Hannah W. Despres
  • , Margaret G. Mills
  •  & Emily A. Bruce

• Article
  26 August 2023 | Open Access

  Post-Covid condition and clinic characteristics associated with SARS-CoV-2 infection: a 2-year follow-up to Brazilian cases

  • Nayara Sousa da Silva
  • , Nathália Kelly de Araújo
  •  & André Ducati Luchessi

• Article
  23 August 2023 | Open Access

  A randomized phase 2 study on demeclocycline in patients with mild-to-moderate COVID-19

  • Kota Iwahori
  • , Takuro Nii
  •  & Atsushi Kumanogoh

• Article
  22 August 2023 | Open Access

  Identifying COVID-19 cases and extracting patient reported symptoms from Reddit using natural language processing

  • Muzhe Guo
  • , Yong Ma
  •  & Fang Jin

• Article
  22 August 2023 | Open Access

  Discovery and multimerization of cross-reactive single-domain antibodies against SARS-like viruses to enhance potency and address emerging SARS-CoV-2 variants

  • Scott A. Hollingsworth
  • , Cameron L. Noland
  •  & Kalyan Pande

• Article
  11 August 2023 | Open Access

  Comparison of genome replication fidelity between SARS-CoV-2 and influenza A virus in cell culture

  • Yoshiko Kawasaki
  • , Haruka Abe
  •  & Jiro Yasuda

• Article
  04 August 2023 | Open Access

  Ultrafast inactivation of SARS-CoV-2 by 254-nm UV-C irradiation on porous and non-porous media of medical interest using an omnidirectional chamber

  • Bertrand Maubert
  • , Camille Theillière
  •  & Emilie Gadea

• Article
  26 July 2023 | Open Access

  A novel approach to finding conserved features in low-variability gene alignments characterises RNA motifs in SARS-CoV and SARS-CoV-2

  • Jordan P. Skittrall
  • , Nerea Irigoyen
  •  & Julia R. Gog